Stay updated on Dupilumab in ABPA Treatment Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page
- Check2 days agoChange DetectedRevision tag on the page changed from v3.6.2 to v3.6.3. This reflects an update to the page's documentation or metadata.SummaryDifference0.0%

- Check10 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer iteration of the study record content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now indicates 'No longer looking for participants', adds new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), standardizes the Intervention/Treatment label, and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check31 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating an internal update; no substantive study information is modified.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's content or metadata.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a technical release of the site interface rather than an update to the trial record.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.